Delivery Order SPE2DB20D3101-SPE2DB24FRUU4
Award Date
9/13/24
Potential Completion Date
9/16/24
Potential Value
$36K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,534,941 Contrave ER 8-90 mg tablets in 120-count bottles. The $3,597.03 firm-fixed-price contract has an ultimate completion date of August 22, 2024. AmerisourceBergen is delivering these pharmaceutical products under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $1,250.40 award is for the supply of 4,563,898,453 units of the medication Contrave ER 8-90 mg tablets. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,243,433 tablets of the drug Contrave ER 8-90 mg, with a ceiling value of $1,199.01. The contract is a firm fixed price Delivery Order with a completion date of July 25, 2024. This contract is not designated as a set-aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed price of $7,792.96 and a completion date of February 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 mg tablets. The award, valued at $23,339.77, has an ultimate completion date of August 13, 2024. The contract is a firm fixed-price delivery order without a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. The $4,509.06 order is for the supply of 120 tablets of the branded prescription medication CONTRAVE ER 8-90 MG. The delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to provide a...
This is a delivery order award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 4,564,389,709 units of the pharmaceutical product Contrave ER 8-90 mg tablets. The award has a ceiling value of $3,739.44 and an ultimate completion date of April 25, 2024. This order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,999.71 contract is for the delivery of 4,567,828,683 units of the prescription medication Contrave ER 8-90 mg tablets. The contract has an ultimate completion date of April 8, 2025 and is not set aside for any special type of business. AmerisourceBergen Drug Corp holds a larger $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Contrave ER 8-90 mg tablets. The contract has a firm fixed price of $4,154.42 and a period of performance through April 15, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of CONTRAVE ER 8-90 mg tablets. The contract has a ceiling value of $5,939.72 and a period of performance through August 26, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the delivery of a comprehensive range of medical commodities to...